Features of cellular structure of the induced sputum and profile of cytokines at sintropiya of bronchial asthma and obesity at young patients
- Authors: Soloveva IA1,2, Sobko EA1,2, Demko IV1,2, Kraposhina AY.1, Loktionova MM1, Gordeeva NV1,2
-
Affiliations:
- Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetsky
- Regional Clinical Hospital
- Issue: Vol 90, No 3 (2018)
- Pages: 25-32
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32722
- DOI: https://doi.org/10.26442/terarkh201890325-32
- ID: 32722
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I A Soloveva
Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetsky; Regional Clinical Hospital
Email: solovieva.irina@inbox.ru
к.м.н., доцент каф. внутренних болезней №2 с курсом ПО, врач-аллерголог Краевого ГБУЗ «Краевая клиническая больница» Krasnoyarsk, Russia
E A Sobko
Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetsky; Regional Clinical Hospitalм.н., доцент каф. внутренних болезней №2 с курсом ПО; зав. отд-нием аллергологии Krasnoyarsk, Russia
I V Demko
Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetsky; Regional Clinical Hospitalд.м.н., проф., зав. каф. внутренних болезней №2 с курсом ПО Krasnoyarsk, Russia
A Yu Kraposhina
Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetskyк.м.н., доцент каф. внутренних болезней №2 с курсом ПО Krasnoyarsk, Russia
M M Loktionova
Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetskyклин. ординатор каф. внутренних болезней №2 с курсом ПО Krasnoyarsk, Russia
N V Gordeeva
Krasnoyarsk state medical university named after prof. V.F. Voino-Yasenetsky; Regional Clinical Hospitalк.м.н., доцент каф. внутренних болезней №2 с курсом ПО; врач-пульмонолог Краевого ГБУЗ «Краевая клиническая больница» Krasnoyarsk, Russia
References
- World Health Organization. Obesity and Overweight. Fact Sheet No 311; http://www.who.int/mediacentre/factsheets/fs311/en/index.html Date last accessed: May 5, 2011.
- Telenga E.D, Tideman S.W, Kerstjens H.A.M, ten Hacken N.H.T, Timens W, Postma D.S, van den Berge M. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy. 2012; 67(8): 1060-1068.
- Beuther D.A, Sutherland E.R. Overweight, obesity, and incident asthma: A meta - analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007; 175: 661-666. doi: 10.1164/rccm.200611-1717OC
- Camargo C.A. Jr, Boulet L.P, Sutherland E.R, Busse W.W, Yancey S.W, Emmett A.H, Ortega H.G, Ferro T.J. Body mass index and response to asthma therapy: Fluticasone propionate/salmeterol versus montelukast. J Asthma. 2010; 47: 76-82.
- Saint-Pierre P, Bourdin A, Chanez P, Daures J.P, Godard P. Are overweight asthmatics more difficult to control? Allergy. 2006;61:79-84. doi: 10.1111/j.1398-9995.2005.00953.x
- Sutherland T.J.T, Cowan J.O, Young S, Goulding A, Grant A.M, Williamson A, Brassett K, Herbison G.P, Taylor D.R. The association between obesity and asthma interactions between systemic and airway Inflammation. All AJRCCM. 2008; 178 (5).
- Bousquet J, Chanez P, Lacoste J.Y, Barnéon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P. Eosinophilic inflammation in asthma. N Engl J Med. 1990; 323: 1033-1039. doi: 10.1056/NEJM199010113231505
- Fahy J.V, Kim K.W, Liu J, Boushey H.A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995; 95: 843-52.
- Turner M.O, Hussack P, Sears M.R, Dolovich J, Hargreave F.E. Exacerbations of asthma without sputum eosinophilia. Thorax. 1995; 50: 1057-1061.
- Douwes J, Gibson P, Pekkanen J, Pearce N. Non - eosinophilic asthma: importance and possible mechanisms. Thorax. 2002; 57: 643-648.
- Kay A.B, Phipps S, Robinson D.S. The role for eosinophils in airway remodeling in asthma. Tends Immunol. 2004; 25: 477-482. doi: 10.1016/j.it.2004.07.006
- Reuter S, Heinz A, Sieren M, Wiewrodt R, Gelfand E.W, Stassen M, Buhl R, Taube C. Mast cell - derived tumor necrosis factor is essential for allergic airway disease. Eur Respir J. 2008; 31: 773-782. doi: 10.1183/09031936.00058907
- Douwes J, Gibson P, Pekkanen J, Pearce N. Non - eosinophilic asthma: importance and possible mechanisms. Thorax. 2002; 57: 643-648.
- Leckie M.J, Brinke A, Khan J, Diamant Z, O'Connor B.J, Walls C.M, Mathur A.K, Cowley H.C, Chung K.F, Djukanovic R, Hansel T.T, Holgate S.T, Sterk P.J, Barnes P.J. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper - responsiveness, and the late asthmatic response. Lancet. 2000; 356: 2144-2148.
- Bryan S.A, O’Connor B.J, Matti S, Leckie M.J, Kanabar V, Khan J, Warrington S.J, Renzetti L, Rames A, Bock J.A, Boyce M.J, Hansel T.T, Holgate S.T, Barneset P.J. Effects of recombinant human interleukin-12 on eosinophils, airway hyper - responsiveness, and the late asthmatic response. Lancet. 2000; 356: 2149-2153.
- Kips J.C, O’Connor B.J, Langley S.J, Woodcock A, Kerstjens H.A, Postma D.S, Danzig M, Cuss F, Pauwels R.A. Effect of SCH55700, a humanised anti - human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med. 2003; 167: 1655-1659. doi: 10.1164/rccm.200206-525OC
- Wilson R.H, Whitehead G.S, Nakano H, Free M.E, Kolls J.K, Cook D.N. Allergic sensitization through the airway primed Th17- dependent neutrophilia and airway hyperresponsiveness. Am J Respir Cm Crit Care. 2009; 180: 720-730.
- Stern J.S, Hirsch J, Blair S.N, Foreyt J.P, Frank A, Kumanyika S.K, Madans J.H, Marlatt G.A, St Jeor S.T, Stunkard A.J. Weighing the options: criteria for evaluating weight - management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res. 1995; 3 (6): 591-604.
- Rio-Navarro В, Cisneros-Rivero M, Berber-Eslava A, Espínola-Reyna G, Sienra-Monge J. Exercise induced bronchospasm in asthmatic and non - asthmatic obese children. Allergol Immunopathol (Madr). 2000; 28 (1): 5-11.
- Shore S.A. Obesity and asthma: location, location, location. Eur Respir J. 2013; 41 (2): 253-254. doi: 10.1183/09031936.00128812
- Авдеев С.Н., Анаев Э.Х., Чучалин А.Г. Применение метода индуцированной мокроты для оценки интенсивности воспаления дыхательных путей. Пульмонология. 1998; 2: 81-85.
- Kips J.C, Fahy J.V, Hargreave F.E. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J. 2008; 11: 9-12.
- Simpson J.L, Scott R, Boyle M.J, Gibson P.G. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006; 11:54-61.
- Ненашева Н.М. Современное представление о фенотипах бронхиальной астмы. Фарматека. 2013; 4: 257.
- Newton R, Leigh R, Glembycz M. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung disease. Prarmacology and Therapeutics. 2010;125:286-327.
- Трофимов В., Миронова Ж. Терапевтически резистентная астма. Врач. 2012;3:2-4.
- Федосеев Г.Б., Трофимов В.И., Рогачева Н.Н., Разумовская Т.С. Роль нейтрофилов и бактериальной инфекции респираторного тракта у больных бронхиальной астмой и хронической обструктивной болезнью легких. Росс. аллергологический журн. 2011; 2: 34-43.
- Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 1995; 154: 4719-4725.
- Shin B, Kwon H.S, Park S.Y, Kim T.B, Moon H.B, Cho Y.S. The transition of sputum inflammatory cell profiles is variable in stable asthma patients. Asia Pac Allergy. 2017; 7 (1): 19-28. doi: 10.5415/apallergy.2017.7.1.19
- Cowan D.C, Cowan J.O, Palmay R, Williamson A, Taylor D.R. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010; 65: 384-390.